CRVS

Corvus Pharmaceuticals Inc

NASDAQ · Biotechnology

$20.46

+1.40 (+7.35%)

Small-Cap Stocks Biotech Stocks Healthcare Stocks

Analyst Consensus

Strong Buy

13 analysts

Buy 12 92%

Hold 1 8%

Sell 0 0%

Price Target

Analyst Price Target +121.9% upside

Low Target $29.32

Average Target $45.40

High Target $54.46

Current Price $20.46

Current
$20.46

Target
$45.40

$29.32 $45.40 avg $54.46